Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Actually in this case the future will be better. When the share price is over 10 maybe we can get back to discussing the science again and the progress of clinical trials and potential new drugs and new indications, instead of the constant sea of negativity and the resultant rebuttals. Agggh.
If there's a cure, they need to be the first ones who get treated lol
It's not just you, unfortunately. (eom)
Bravo, Sox. I guess people have their choice with who they want to believe, the people who have been here and understand the history, and science, and the potential -- and also the statements of management; or the people who are unrelentingly negative and who keep posting the same incorrect claims over and over, despite those claims being refuted.
I continue to be in for the long haul. My initial buy was at .79, the stock promptly tanked, I disgustedly doubled down at .31, and have continued buying through all the ups and downs. I don't regret a single purchase.
You may have a long wait.... I hope..... lol
You may have called it. All of a sudden 3 cent spread, low volume for the day.... maybe this is it. Would be nice to see all the shorts covering, all the sellers done selling. Mr. T would say "Pity the fool who" is short or underweighted in CTIX if there's a press release Monday.
It's not a matter of scaring "self," it's a matter of trying to scare others.
Won't work. People who haven't been shaken out up till now are going to hang on no matter what games are attempted or what disinformation comes down the pike.
In a word, yes. Your observations on the big seller and difference in the way it's trading have been very helpful -- thanks.
The difference is that Hep C can be fatal, while psoriasis isn't, so insurance companies may not be as willing to pay up. We're all speculating anyway but I'm just saying let's not get too pie in the sky with valuation. I posted years ago that if it works for psoriasis, it might work on other diseases -- would be fantastic if it also worked for things like rheumatoid arthritis.
I continue to think that this is going to be like JAZZ, PCYC etc that have had stupendous runs. And we're in on the ground floor. Well, at least those of us who genuinely own the stock.
A big difference between Prurisol and Humira is that Humira is a maintenance drug, taken constantly, and Prurisol may be a cure, or at least last for several months on one course of treatment. (An actual cure would be unbelievably great for the patients.) So the huge profits are made in drugs that have to be taken repeatedly, not in a drug that is taken only occasionally, or maybe even only one course of treatment. I'd be careful about sales projections in the psoriasis area for that reason.
However, if it is useful for other diseases too, well.....
Spread has usually been 1 or 2 cents, and we should care because it indicates a change in the way the stock is trading.
If you believe what you posted "Of course share price is not a reliable indicator" then why did you earlier post this?
Share price and scientific results have no correlation. Any experienced biotech investor has seen plenty of times when share price has been extremely high with few if any results, and other times that share price does not accurately reflect the value of the science.
Surely you know that the "efficient market" hypothesis has been shown to be wrong many times.
Anyone who read TOB's post knows the response to spurious claims.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114310548
I hope that those last few trades were the remnants of panicked shorts covering their positions. If, as I Need Help postulates, the giant selling pressure is off, this should now be (appropriately for summer) like trying to keep a beach ball underwater.
Nope, since you are the one making unfounded statements, the burden of proof is on you to support your insupportable position. No reason for me to continue to rebut something that everyone else knows is not true.
You might want to read this other post in response to yours first:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=114309084
Last trade 2.84 ? ? ? ?
So wrong.
AKA "walking it down" (in reference to the "dreaded 100 share syndrome")
No, but I heard the one about the desperate shorts who kept posting a bunch of malarkey to try to demoralize the strong hands who understand what the company was doing, and are going to keep holding until the stock is fairly valued, at many times the current share price.
Funny, I don't think Mr. Ehrlich is the one who sounds desperate.
Looks like iHub fixed the quadruple-posting problem etc. I'm trying out the ignore feature and so far so good, seems to work.
Good work, Scott and noretreat. Great to have that response. I'd like to say "that should put an end to the speculation" but I doubt that it will.
My guess for tomorrow:
There will be another attempt to scare any remaining weak hands out of their shares. Probably re-test today's lows, if not even further.
Some people will sell other stocks to raise cash to buy CTIX at bargain prices. (That one is 100% certain, if I count as "some people")
Some posters will continue to claim that the information Scott and noretreat shared with us must be wrong. The rest of us will smile sardonically.
"I would find a way to fight back" -- so you mean someone who was long might post trying to counteract misinformation that might scare newbie investors away? Conversely someone who was short and worried about the position might post unrelentingly bearish, inaccurate misinformation like a broken record, despite correct information being posted, don't you think?
LOL I wondered about that too (eom)
Vlady, I don't remember the exact quote but it's something like "the purpose of the stock market is to separate as many people as possible from their money." One of the things that so often happens is that the small investor gets out of stocks right before they go up. I could name many example from my own and from my friends' experience. I agree with the others who have posted about how rare it is for small investors to have a chance to get in on the ground floor, and I am NOT going to get scared out of a stock that has potentially game-changing drugs in 3 different areas, with a market cap of only 309 million. Kevetrin or Brilacidin each ought to warrant a market cap of that size.
"Efficient markets," bah, humbug.
Bravo, CallMeCrazy. I call you Smart. (eom)
How can anyone "wonder if the numbers are any good" if they read the ASCO poster?
Desperation.
There are lots of reasons why the p21 data isn't out yet. For instance:
It would be partial data, since the trial isn't over yet.
They won't have data yet on the most recent enrollees in the trial.
They want to have statistically significant data on enough people so that they can eliminate the data on the extreme low-dose trial participants from the first several cohorts (who probably didn't have a response because the dose was so low), and there aren't enough people at higher doses yet.
And, if there is indeed mind-blowing news, they won't want to release partial data now, and potentially endanger the possibility of publication in one of the most prestigious journals because it's "old news."
Why do you assume Brilacidin requires more than one dose, and Vancomycin only one, when the reverse seems to be true from studies so far? Are you assuming Brilacidin will always be given intravenously for all purposes? Why do you say Brilacidin has a longer half-life when it has a shorter half-life?
I agree Bizzy, I also have both stocks but CTIX is by far the less risky. I too find it puzzling that that super-dangerous penny stock doesn't receive the negativity that the largely-de-risked CTIX is getting. CTIX's price reflects at most the value of Kevetrin OR Brilacidin, with the other two drugs thrown in for free. The other stock -- promising but very very speculative at this point. How the stock with multiple clinical trials of several different drugs is somehow perceived as bad, and the risky penny stock is so exciting -- well, beyond me. (I remain long the other one too, but it was CTIX I bought more of today)
Yecccch I am grossed out. Brilacidin disinfecting spray, bring it on.
Conference is over now. He said "the events" which sounds like there is more than just a rehash of the data on the poster. On the other hand, even if it is just a summary of the poster, that will be helpful in getting the word out, because most people aren't going to slog through hundreds of posters, they read press releases.
Underarm zits EDIT that was a response to a question, not a commentary on anything! Although "underarm zits" gets points for being a new fun expletive
I'd think Bril-Ocular would be a much lower priority now. However I do think that eventually that would be a useful thing for eye surgery --for instance cataract surgery, in which the corneal penetration issue shouldn't be a problem, since the cornea is cut (study said that a cut in the cornea allowed penetration of the drug). But I'd think that would involve a whole new set of animal studies -- you can't exactly try an experimental drug in human eyes, when if it doesn't work the result is horrible infection and probably blindness. I can't imagine an ethics committee approving that trial without compelling results in animal studies.
Thanks JohnB. Whether or not the author was correct about that stock, I did laugh out loud when I ran across this line:
F1ash what article is it that you're talking about? link please
@I Need Help, I agree with you. I think there's still some supply there from Aruda lawyers.
If I weren't already grossly overweighted I would buy more at these levels.
haha well that question about buyout at 10 got some interesting and fun responses. ("how many idiots" -- literally laughed out loud)
And I think that's a great interpretation, "the events" -- maybe there WAS an event we'll be finding out about... hmmmm.....
Just curious -- if someone wanted to buy out the whole company for 10/share, how many would vote yes for that? (In other words, no chance to trade part or anything like that -- all would have to go with no possibility of re-entry)